X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with BATA INDIA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs BATA INDIA - Comparison Results

BATA INDIA 
   Change

Bata is India's largest footwear retailer of India. It is a part of the Bata Shoe Organisation and was incorporated in the year 1931. The company also manufactures footwear and has a wide retail network of over 1200 stores across India. It sells over... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES BATA INDIA AMAR REMEDIES/
BATA INDIA
 
P/E (TTM) x -0.5 51.7 - View Chart
P/BV x 0.1 9.1 0.7% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 AMAR REMEDIES   BATA INDIA
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
BATA INDIA
Mar-18
AMAR REMEDIES/
BATA INDIA
5-Yr Chart
Click to enlarge
High Rs164833 19.7%   
Low Rs86511 16.8%   
Sales per share (Unadj.) Rs261.6204.9 127.7%  
Earnings per share (Unadj.) Rs17.417.2 101.4%  
Cash flow per share (Unadj.) Rs22.321.9 101.9%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs100.7114.7 87.8%  
Shares outstanding (eoy) m26.16128.53 20.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.53.3 14.6%   
Avg P/E ratio x7.239.2 18.4%  
P/CF ratio (eoy) x5.630.7 18.3%  
Price / Book Value ratio x1.25.9 21.2%  
Dividend payout %023.3 0.0%   
Avg Mkt Cap Rs m3,27086,340 3.8%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m1632,956 5.5%   
Avg. sales/employee Rs ThNM5,607.0-  
Avg. wages/employee Rs ThNM629.2-  
Avg. net profit/employee Rs ThNM469.4-  
INCOME DATA
Net Sales Rs m6,84426,342 26.0%  
Other income Rs m21503 4.2%   
Total revenues Rs m6,86526,845 25.6%   
Gross profit Rs m1,1313,514 32.2%  
Depreciation Rs m128605 21.2%   
Interest Rs m39842 947.6%   
Profit before tax Rs m6263,370 18.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-500-   
Tax Rs m1211,165 10.4%   
Profit after tax Rs m4552,205 20.6%  
Gross profit margin %16.513.3 123.9%  
Effective tax rate %19.334.6 55.9%   
Net profit margin %6.68.4 79.4%  
BALANCE SHEET DATA
Current assets Rs m4,90415,549 31.5%   
Current liabilities Rs m3,5815,608 63.9%   
Net working cap to sales %19.337.7 51.2%  
Current ratio x1.42.8 49.4%  
Inventory Days Days124106 117.2%  
Debtors Days Days10012 809.0%  
Net fixed assets Rs m1,6893,070 55.0%   
Share capital Rs m262643 40.8%   
"Free" reserves Rs m2,35814,104 16.7%   
Net worth Rs m2,63514,747 17.9%   
Long term debt Rs m5070-   
Total assets Rs m6,86221,414 32.0%  
Interest coverage x2.681.2 3.2%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.2 81.1%   
Return on assets %12.410.5 118.5%  
Return on equity %17.315.0 115.5%  
Return on capital %31.023.1 134.0%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m273161 169.6%   
Fx outflow Rs m22,648 0.1%   
Net fx Rs m271-2,487 -10.9%   
CASH FLOW
From Operations Rs m-3131,603 -19.5%  
From Investments Rs m-489-1,119 43.7%  
From Financial Activity Rs m769-556 -138.3%  
Net Cashflow Rs m-33-72 45.2%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 53.0 -  
Indian inst/Mut Fund % 9.2 9.8 93.9%  
FIIs % 0.0 20.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 17.1 381.9%  
Shareholders   13,061 83,621 15.6%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   EMAMI LTD  LINC PEN & PLASTICS LTD  MARICO LTD  P&G HYGIENE  GODREJ CONSUMER  

Compare AMAR REMEDIES With:   P&G (US)  UNILEVER PLC. (UK)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Plunges Over 500 Points; Power & Realty Stocks Hit Hardest(09:30 am)

Asian stock markets are lower today as Japanese and Hong Kong shares fall. he Nikkei 225 is off 2.3% while the Hang Seng is down 1.7%.

Related Views on News

BATA INDIA Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, BATA INDIA has posted a net profit of Rs 557 m (up 29.8% YoY). Sales on the other hand came in at Rs 7 bn (up 14.7% YoY). Read on for a complete analysis of BATA INDIA's quarterly results.

BATA INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Oct 5, 2018 | Updated on Oct 5, 2018

Here's an analysis of the annual report of BATA INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of BATA INDIA. Also includes updates on the valuation of BATA INDIA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS